Cleveland Clinic Expands AI Partnership with AKASA to Revolutionize Revenue Cycle Management

Cleveland Clinic, a leading U.S. academic medical center, is significantly scaling its collaboration with AKASA, a prominent healthcare artificial intelligence (AI) firm. The expanded partnership will deploy an advanced Clinical Documentation Integrity (CDI) solution across all Cleveland Clinic locations nationwide, building on the success of a previously implemented AI-powered coding tool. This move underscores a growing trend toward leveraging generative AI (GenAI) to address complex financial challenges within the healthcare industry.

The Rise of AI in Healthcare’s Mid-Revenue Cycle

The healthcare revenue cycle, particularly the mid-revenue cycle, is a notoriously complex process. Accurate clinical documentation and precise medical coding are paramount, serving as the foundation for appropriate reimbursement and ensuring compliance with ever-evolving regulations. Inaccurate or incomplete documentation can lead to claim denials, delayed payments, and significant financial losses for healthcare providers.

Earlier this year, Cleveland Clinic demonstrated its commitment to innovation by implementing AKASA’s AI coding tool, achieving a rapid, system-wide rollout across all U.S. facilities in just four months. This initial deployment successfully processed tens of thousands of patient encounters, showcasing the potential of AI to streamline coding operations and improve efficiency.

Now, the focus shifts to Clinical Documentation Integrity (CDI), a process even more nuanced than coding. CDI specialists are tasked with meticulously reviewing patient records – encompassing not only coded data but also a wealth of multi-modal information like laboratory results, imaging reports, vital signs, and medication lists – to ensure the clinical record comprehensively supports the services billed. The new GenAI-powered CDI solution acts as an intelligent assistant, augmenting the expertise of CDI staff and dramatically increasing their accuracy and productivity.

This isn’t simply about automating tasks; it’s about empowering healthcare professionals with the tools they need to navigate an increasingly complex landscape. How can healthcare organizations balance the implementation of AI with the need to maintain a human touch in patient care?

The CDI solution operates on a unified platform, seamlessly integrating documentation and coding into a cohesive workflow. Critically, the system is designed to adapt to the unique clinical and operational characteristics of each healthcare system, providing a customized experience and surfacing relevant clinical evidence directly to staff. This allows CDI professionals to prioritize their time effectively, focusing on cases that require their specialized expertise.

“Expanding the breadth of our work with Cleveland Clinic is a powerful example of what’s possible when health systems and technology partners tackle the toughest challenges together,” stated Malinka Walaliyadde, CEO and co-founder of AKASA. “By addressing documentation and coding at scale, we’re proving that AI can finally close long-standing gaps in the revenue cycle. And when health systems can fully capture the complexity of patient care, everyone benefits, from clinicians to revenue cycle staff to patients themselves.”

Cleveland Clinic’s proactive adoption of this technology signals a significant step toward establishing GenAI as a standard practice for financial integrity in healthcare. The widespread deployment represents one of the most comprehensive real-world applications of GenAI in healthcare finance to date.

“Integrating advanced AI solutions into our revenue cycle is a testament to Cleveland Clinic’s commitment to innovation and operational excellence,” said Ben Shahshahani, Ph.D., Chief AI Officer at Cleveland Clinic. “The success of the AI coding platform has demonstrated the transformative impact of technology in enhancing efficiency and quality. With the launch of the CDI solution, we are excited to continue setting new benchmarks for how AI can support our teams, improve processes, and ultimately benefit our patients.”

Beyond Cleveland Clinic, other healthcare systems are beginning to explore the potential of AI-driven CDI solutions. What are the key barriers preventing wider adoption of these technologies across the industry?

Did You Know? The U.S. healthcare revenue cycle is estimated to be a $3.5 trillion market, making even small efficiency gains through AI adoption incredibly impactful.

Further bolstering the trend, a recent report by McKinsey & Company highlights the potential for generative AI to unlock significant value across the healthcare value chain, including revenue cycle management. The report estimates that AI could automate up to 30% of healthcare administrative tasks.

Another key player in the healthcare AI space, Google Health, is also actively developing AI-powered solutions for clinical documentation and coding, further validating the growing importance of this technology.

Frequently Asked Questions About AI in Healthcare Revenue Cycle Management